AstraZeneca’s CEO said the company has proposed U.S. price cuts to some drugs, while Doximity enters competitive AI scribing ...

Bristol-Myers Squibb unveils its earnings this Thursday. Last quarter, they beat revenue estimates by nearly 4%. Now, ...

Indiana saw the second biggest small business growth in July, while President Trump is expected to impose tariffs on medicine ...

AI-powered quantification of tumor-infiltrating lymphocytes could change how patients with melanoma are treated after surgery ...

You also don't need a substantial amount of money on hand to invest. Here are three prominent healthcare companies you can ...

Biopharmaceutical company Bristol Myers Squibb (NYSE:BMY) will be reporting results this Thursday morning. Here’s what you ...

Bristol Myers Squibb and Bain Capital have formed a new independent biopharmaceutical company focused on developing new ...

AbbVie, Bristol Myers Squibb and Eli Lilly appear “relatively well-positioned,” while Novartis and Roche look more at risk, ...

The FDA has accepted for review the sNDA for deucravacitinib for the treatment of adults with active psoriatic arthritis.

Drugmaker Bristol Myers Squibb and private equity firm Bain Capital will launch an independent company focused on developing ...

Bristol Myers will get a nearly 20% stake in the startup, which will be led by one of its former executives and advance five ...